Multiple endocrine neoplasia type 1. Surgical therapy of primary hyperparathyroidism

被引：14

作者：

Langer P. ^{[1
,2
]}

Wild A. ^{[1
]}

Schilling T. ^{[1
]}

Nies C. ^{[1
]}

Rothmund M. ^{[1
]}

Bartsch D.K. ^{[1
]}

机构：

[1] Klin. F. Visc.-, Thorax- G., Philipps-Universität Marburg

[2] Klin. F. Visc.-, Thorax- G., Philipps-Universität, 35043 Marburg, Baldingerstraße

来源：

Der Chirurg | 2004年 / 75卷 / 9期

关键词：

Hypocalcemia; Multiple endocrine neoplasia type 1; Primary hyperparathyroidism; Total parathyroidectomy with autotransplantation;

D O I：

10.1007/s00104-004-0838-4

中图分类号：

学科分类号：

摘要：

Primary hyperparathyroidism (pHPT) occurs in about 90% of patients with multiple endocrine neoplasia type 1 (MEN1). In contrast to sporadic pHPT, multiple gland disease is most common in MEN1. The appropriate surgical approach is still controversial. The aim of this study was to analyze the results of surgical therapy of pHPT in patients with genetically confirmed MEN1. In an observational study, preoperative data, operative procedures, long-term results, and a possible genotype-phenotype correlation were analyzed in patients with pHPT and genetically confirmed MEN1. According to our results, tPTX+T (total parathyroidectomy+thymectomy+autotransplantation) seems to be a more favorable surgical approach in patients with MEN1 pHPT than sDE (selective gland exstirpation) and stPTX (subtotal parathyroidectromy) without cervical thymectomy, because recurrences or persistence of the disease are rare. A prospective randomized trial is needed to compare stPTX including cervical thymectomy vs tPTX+T. A genotype-phenotype correlation could not be identified.

引用

页码：900 / 906

页数：6

共 32 条

[1]

Antoniucci D.M., Shoback D., Calcimimetics in the treatment of primary hyperparathyreoidism, J Bone Miner Res, 17, 2 SUPPL., (2002)

[2]

Bartsch D., Kopp I., Bergenfelz A., Et al., MEN1 gene mutations in 12 MEN1 families and their associated tumors, Eur J Endocrinol, 139, (1998)

[3]

Bartsch D.K., Langer P., Wild A., Schilling T., Celik I., Rothmund M., Nies C., Pancreticoduodenal endocrine tumors in multiple endocrine neoplasia type 1 - Surgery or surveillance?, Surgery, 128, (2000)

[4]

Benson L., Ljunghall S., Akerstrom G., Oberg K., Hyperparathyroidism presenting as the first lesion in multiple endocrine neoplasia type 1, Am J Med, 82, (1987)

[5]

Brandi M.L., Gagel R.F., Angeli A., Et al., Guidelines for diagnosis and therapy of MEN type 1 and type 2, J Clin Endocrinol Metab, 86, (2001)

[6]

Burgess J.R., David R., Parameswaran V., Greenaway T.M., Shepherd J.J., The outcome of subtotal parathyroidectomy for the treatment of hyperparathyroidism in multiple endocrine neoplasia type 1, Arch Surg, 133, (1998)

[7]

Burgess J.R., David R., Greenaway T.M., Parameswaran V., Shepherd J.J., Osteoporosis in multiple endocrine neoplasia type 1, Arch Surg, 134, (1999)

[8]

Carty S.E., Helm A.K., Amico J.A., Et al., The variable penetrance and spectrum of manifestations of multiple endocrine neoplasia type 1, Surgery, 124, (1998)

[9]

Casanova D., Sarfati E., De Francisco A., Amado J.A., Arias M., Dubost C., Secondary hyperparathyroidism: Diagnosis of site of recurrence, World J Surg, 15, (1991)

[10]

Chandrasekharappa S.C., Guru S.C., Manickam P., Et al., Positional cloning of the gene for multiple endocrine neoplasia type 1, Science, 276, (1997)

← 1 2 3 4 →